Skandinaviska Enskilda Banken (SEB)’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-87,185
| Closed | -$17.9M | – | 248 |
|
|
2025
Q4 | $17.9M | Buy |
87,185
+20,806
| +31% | +$3.92M | 0.07% | 194 |
|
|
2025
Q3 | $10.4M | Sell |
66,379
-13,909
| -17% | -$2.15M | 0.04% | 273 |
|
|
2025
Q2 | $13.5M | Sell |
80,288
-25,248
| -24% | -$3.75M | 0.06% | 241 |
|
|
2025
Q1 | $14.5M | Sell |
105,536
-271,581
| -72% | -$34.6M | 0.07% | 222 |
|
|
2024
Q4 | $44.5M | Sell |
377,117
-94,271
| -20% | -$11M | 0.2% | 89 |
|
|
2024
Q3 | $52.1M | Sell |
471,388
-360,197
| -43% | -$37.7M | 0.24% | 75 |
|
|
2024
Q2 | $81.8M | Sell |
831,585
-166,302
| -17% | -$16.9M | 0.39% | 47 |
|
|
2024
Q1 | $112M | Buy |
997,887
+369,965
| +59% | +$39.9M | 0.55% | 31 |
|
|
2023
Q4 | $63.3M | Buy |
627,922
+196,965
| +46% | +$19.5M | 0.37% | 50 |
|
|
2023
Q3 | $37.4M | Buy |
430,957
+70,030
| +19% | +$6.33M | 0.25% | 79 |
|
|
2023
Q2 | $34.1M | Buy |
360,927
+177,828
| +97% | +$15M | 0.22% | 92 |
|
|
2023
Q1 | $13.8M | Buy |
183,099
+134,310
| +275% | +$10.1M | 0.1% | 223 |
|
|
2022
Q4 | $3.75M | Buy |
48,789
+3,718
| +8% | +$283K | 0.03% | 411 |
|
|
2022
Q3 | $3M | Sell |
45,071
-2,695
| -6% | -$171K | 0.02% | 458 |
|
|
2022
Q2 | $2.5M | Sell |
47,766
-946
| -2% | -$53.8K | 0.02% | 515 |
|
|
2022
Q1 | $2.76M | Sell |
48,712
-2,245
| -4% | -$120K | 0.02% | 543 |
|
|
2021
Q4 | $2.66M | Sell |
50,957
-1,881
| -4% | -$92.3K | 0.01% | 580 |
|
|
2021
Q3 | $2.61M | Sell |
52,838
-5
| -0% | -$271 | 0.01% | 576 |
|
|
2021
Q2 | $3.02M | Sell |
52,843
-13,481
| -20% | -$788K | 0.02% | 554 |
|
|
2021
Q1 | $4.03M | Buy |
66,324
+13,405
| +25% | +$740K | 0.03% | 444 |
|
|
2020
Q4 | $2.83M | Sell |
52,919
-12,212
| -19% | -$634K | 0.02% | 522 |
|
|
2020
Q3 | $3.06M | Sell |
65,131
-140,938
| -68% | -$7.23M | 0.02% | 445 |
|
|
2020
Q2 | $10.8M | Sell |
206,069
-14,871
| -7% | -$767K | 0.09% | 212 |
|
|
2020
Q1 | $10.6M | Sell |
220,940
-52,713
| -19% | -$2.74M | 0.11% | 176 |
|
|
2019
Q4 | $13.8M | Sell |
273,653
-78,914
| -22% | -$4.08M | 0.11% | 174 |
|
|
2019
Q3 | $16.6M | Sell |
352,567
-1,222,101
| -78% | -$55.8M | 0.14% | 141 |
|
|
2019
Q2 | $74.2M | Buy |
1,574,668
+105,389
| +7% | +$4.86M | 0.64% | 33 |
|
|
2019
Q1 | $70.7M | Buy |
1,469,279
+1,415,551
| +2,635% | +$70.9M | 0.65% | 37 |
|
|
2018
Q4 | $2.4M | Sell |
53,728
-5,564
| -9% | -$290K | 0.02% | 428 |
|
|
2018
Q3 | $3.2M | Sell |
59,292
-300
| -0.5% | -$15.4K | 0.02% | 386 |
|
|
2018
Q2 | $2.91M | Buy |
59,592
+20,302
| +52% | +$1.15M | 0.02% | 357 |
|
|
2018
Q1 | $2.46M | Sell |
39,290
-24,279
| -38% | -$1.67M | 0.02% | 345 |
|
|
2017
Q4 | $3.9M | Buy |
63,569
+8,317
| +15% | +$514K | 0.03% | 323 |
|
|
2017
Q3 | $3.7M | Sell |
55,252
-116,600
| -68% | -$8.24M | 0.03% | 343 |
|
|
2017
Q2 | $13.4M | Sell |
171,852
-1,200
| -0.7% | -$90.6K | 0.13% | 157 |
|
|
2017
Q1 | $14.1M | Sell |
173,052
-2,015
| -1% | -$159K | 0.14% | 134 |
|
|
2016
Q4 | $12.6M | Buy |
175,067
+1,235
| +0.7% | +$89.3K | 0.15% | 116 |
|
|
2016
Q3 | $13.5M | Sell |
173,832
-413,900
| -70% | -$33.4M | 0.15% | 115 |
|
|
2016
Q2 | $45.8M | Sell |
587,732
-13,800
| -2% | -$1.1M | 0.51% | 39 |
|
|
2016
Q1 | $49.3M | Sell |
601,532
-4,800
| -0.8% | -$390K | 0.55% | 34 |
|
|
2015
Q4 | $54.1M | Buy |
+606,332
| New | +$51.5M | 0.7% | 29 |
|
Other funds holding CAH
VCM
VPM
Skandinaviska Enskilda Banken (SEB)'s CAH Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 87,185 shares — an estimated $17.9M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in CAH in Q4 2015 and held it in 41 quarters. The position peaked at $112M in Q1 2024. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 87,185 Cardinal Health shares in Q1 2026, an estimated $17.9M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Cardinal Health in Q4 2015 and held it in 41 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Cardinal Health position peaked at $112M in Q1 2024.
- 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.